烟草工业赞助在持续专业发展中没有任何位置
Leslie London1, Mvuyiso Talatala2,3, Bilkish Cassim4
1Division of Public Health Medicine, School of Public Health, University of Cape Town, Cape Town, South Africa.
概括
烟草行业的发展
科学领域:
- 公共卫生 公共卫生
- 医学伦理 医学伦理
背景情况:
- 持续专业发展 (CPD) 对医疗保健专业人员的能力至关重要.
- 独立的CPD交付是必不可少的,不受既得利益的影响.
- 烟草行业对CPD的赞助构成道德挑战,可能违反国际烟草控制协议.
研究的目的:
- 在持续专业发展 (CPD) 中解决烟草行业赞助的伦理影响.
- 倡导采取政策,防止烟草行业对医疗保健专业人员教育的影响.
主要方法:
- 分析烟草行业赞助CPD所带来的伦理挑战.
- 审查南非医学院 (CMSA) 对烟草赞助的立场.
- 审查南非"烟草控制框架公约"的义务.
主要成果:
- 烟草行业试图赞助CPD的行为造成了伦理冲突.
- 南非医学院 (CMSA) 禁止烟草公司赞助CPD.
- 这一立场符合CMSA的伦理任务和国际烟草控制义务.
结论:
- 医疗机构应该拒绝烟草行业对CPD的赞助.
- 南非卫生职业委员会 (HPCSA) 应指导认证机构排除烟草赞助的CPD.
- 这是关键的,因为南非正在考虑新的烟草控制立法.
相关概念视频
PPE Use in Healthcare Settings II: Doffing
1.5K
The sequence of removing or doffing PPE starts with the gloves, as they are the most contaminated. Next is removal of the face shield or goggles, as they would interfere with removing other PPE. Then remove the gown, followed by the mask or respirator. Perform hand hygiene between steps if hands become contaminated and immediately after removing all PPE. Generally, the outside front and sleeves of the isolation gown, the goggles or the mask, the respirator, and the face shield are contaminated.
1.5K
PPE Use in Healthcare Settings I: Donning
1.6K
Donning PPE must be completed before contact with the patient. This process protects from infectious agents. The sequence and action included in each donning are critical, and the steps must be systematic to avoid exposure to pathogens. The institutional policy also needs to be followed while donning PPE. The pre-donning preparations are gathering equipment, inspecting the PPE equipment for tears, holes, or damage, removing jewelry, removing any garments below the elbows, and tying the hair...
1.6K
Peripheral Artery Disease III: Interprofessional Care
248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248
Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Levels of Health Promotion and Illness Prevention
14.3K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
14.3K
Drug Control Governance: Regulatory Bodies and Their Impact
496
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
496


